All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

Boston biotech Bambusa banks $90M for next-gen bispecifics

Boston biotech Bambusa banks $90M for next-gen bispecifics

Feb 14, 2025  0

Eye surgery specialist BVI Medical claims $1B capital raise through owner TPG

Eye surgery specialist BVI Medical claims $1B capital r...

Mar 13, 2025  0

Clario acquires WCG's neuroscience-focused clinical outcome assessment business

Clario acquires WCG's neuroscience-focused clinical out...

Mar 12, 2025  0